SCHEMBL4261249

SCHEMBL4261249

Cc1nccnc1-c1csc(C2CCNCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.50
▸ BAZ2A Q9UIF9 3/20 0.46
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ NPY5R Q15761 1/20 0.35
▸ AOC3 Q16853 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KCNH2 Q12809 3/20 0.34
▸ MKNK1 Q9BUB5 2/20 0.33
▸ MKNK2 Q9HBH9 2/20 0.33
▸ TLR9 Q9NR96 1/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2980048 0.99 HPGDS (0.49) HPGDSBAZ2AMEN1KMT2ANPY5R
SCHEMBL2984450 0.78 CHRM4 (0.36) BAZ2ANPY5R
SCHEMBL2984991 0.76 ALDH1A1 (0.40) BAZ2ANPY5RKCNH2TLR9TLR8
SCHEMBL4262100 0.74 HPGDS (0.59) HPGDSBAZ2AMEN1KMT2ANPC1
SCHEMBL13422226 0.74 HPGDS (0.52) HPGDSBAZ2AMEN1KMT2AAOC3
SCHEMBL1042507 0.74 HPGDS (0.47) HPGDSBAZ2AMEN1KMT2AAOC3
SCHEMBL4265265 0.74 HPGDS (0.61) HPGDSBAZ2AMEN1KMT2AAOC3
Bromide SCHEMBL2983628 0.73 HPGDS (0.57) HPGDSBAZ2AMEN1KMT2ANPC1
Bromide SCHEMBL2984301 0.72 HPGDS (0.60) HPGDSBAZ2AMEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL17541611 0.72 HPGDS (0.46) HPGDSBAZ2AMEN1KMT2AAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945635-B1 THIAZOLYL PIPERIDINE DERIVATIVES USEFUL AS H3 RECEPTOR MODULATORS HOFFMANN LA ROCHE (CH) 2009-05-06 — — EP disclosed
CN-101243078-A Thiazolyl piperidine derivatives useful as h3 receptor modulators HOFFMANN LA ROCHE (CH) 2008-08-13 — — CN disclosed
Send feedback